Ming Wang

No. 55, South Renmin Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

An oxidative stress - and immunotherapy-related six-gene signature defines immune subtypes and predicts prognosis and immunotherapy response in hepatocellular carcinoma.

An oxidative stress - and immunotherapy-related six-gene signature defines immune subtypes and predicts prognosis and immunotherapy response in hepatocellular carcinoma.

Journal: Gene

Published: May 22, 2026

S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H2S-linked vascular and immune reprogramming.

S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H2S-linked vascular and immune reprogramming.

Journal: Journal of translational medicine

Published: February 26, 2026

Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study.

Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study.

Journal: Frontiers in immunology

Published: February 11, 2026

TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study.

TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study.

Journal: Frontiers in immunology

Published: February 02, 2026

Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma.

Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma.

Journal: European journal of radiology

Published: November 13, 2025

Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancreatic cancer.

Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancreatic cancer.

Journal: BMC cancer

Published: November 03, 2025

Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis.

Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis.

Journal: Frontiers in immunology

Published: July 01, 2025

FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.

FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: June 05, 2025

A Comparative Study of Five Large Language Models' Response for Liver Cancer Comprehensive Treatment.

A Comparative Study of Five Large Language Models' Response for Liver Cancer Comprehensive Treatment.

Journal: Journal of hepatocellular carcinoma

Published: April 15, 2025

Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study.

Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study.

Journal: Frontiers in immunology

Published: April 10, 2025

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Journal: Signal transduction and targeted therapy

Published: November 03, 2024

Association of cholecystectomy with osteoporosis risk: a prospective study using data from the UK Biobank.

Association of cholecystectomy with osteoporosis risk: a prospective study using data from the UK Biobank.

Journal: Frontiers in endocrinology

Published: July 16, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026